首页> 外国专利> FORMULATION FOR THE ORAL PURPOSE OF THE TOTAL ECONOMIC TREATY AS CO-ADJUVANCE FOR HUMAN HEALTH

FORMULATION FOR THE ORAL PURPOSE OF THE TOTAL ECONOMIC TREATY AS CO-ADJUVANCE FOR HUMAN HEALTH

机译:作为人类健康共同辅助的总经济条约的口头宗旨

摘要

The invention relates to a nutraceutical formulation of blueberry extract, fish oil (omega-3 and omega-6), recombinant human lactoferrin, vitamin A and vitamin E, for human oral consumption. The invention belongs to the field of ophthalmology and has been developed as a coadjuvant for preserving the health of the precorneal film and of the eye surface. This formulation contains an extract of natural origin (Vaccinium myrtillus L) with antioxidant and anti-inflammatory properties; it also uses eicosapentaenoic acid (EPA), omega-6, and docosahexaenoic acid (DHA), omega-3, obtained from fish oil and which, together with lactoferrin, vitamin A and vitamin E, improves tear quality, since these compounds have anti-microbial and anti-inflammatory effects. This formulation has been designed as a coadjuvant for preserving the health of the precorneal film. No formulation for oral administration of a blueberry extract together with lactoferrin, in combination with vitamin A, vitamin E and fish oil (eicosapentaenoic acid and docosahexaenoic acid) is found in the prior art, nor is the use of this formulation as an adjuvant for preserving the health of the precorneal film and/or the eye surface.
机译:本发明涉及蓝莓提取物,鱼油(Omega-3和Omega-6),重组人乳铁蛋白,维生素A和维生素E的Nutraceutical制剂,用于人口服消耗。本发明属于眼科的领域,并且已被开发为用于保留前甲膜和眼表面的健康的Coadjuvant。该制剂含有天然来源(疫苗菌状物L)的提取物,具有抗氧化剂和抗炎特性;它还使用从鱼油中获得的eicosapentaeno酸(EPA),Omega-6和DOMOSahexoonoider(DHA),ω-3,与乳铁蛋白,维生素A和维生素E一起,提高了泪液质量,因为这些化合物具有抗-microbial和抗炎作用。该配方设计为Coadjuvant,用于保存前甲膜的健康状况。在现有技术中发现了与维生素A,维生素E和鱼油(己二辛烯酸和十二磺酸鱼油(己磺酰庚酸和二十二磺酸)组合的蓝莓提取物的口服施用的配方,也不是使用该配方作为保存的佐剂前膜和/或眼表面的健康。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号